Main results
We included four trials involving more than 13,000 women. All four studies included women in labour. Overall, the studies were at low risk of bias. Although not statistically significant using a strict P < 0.05 criterion, data are consistent with women allocated to admission CTG having, on average, a higher probability of an increase in incidence of caesarean section than women allocated to intermittent auscultation (risk ratio (RR) 1.20, 95% confidence interval (CI) 1.00 to 1.44, four trials, 11,338 women, T² = 0.00, I² = 0%). There was no significant difference in the average treatment effect across included trials between women allocated to admission CTG and women allocated to intermittent auscultation in instrumental vaginal birth (RR 1.10, 95% CI 0.95 to 1.27, four trials, 11,338 women, T² = 0.01, I² = 38%) and fetal and neonatal deaths (RR 1.01, 95% CI 0.30 to 3.47, four trials, 11339 infants, T² = 0.00, I² = 0%).
Women allocated to admission CTG had, on average, significantly higher rates of continuous electronic fetal monitoring during labour (RR 1.30, 95% CI 1.14 to 1.48, three trials, 10,753 women, T² = 0.01, I² = 79%) and fetal blood sampling (RR 1.28, 95% CI 1.13 to 1.45, three trials, 10,757 women, T² = 0.00, I² = 0%) than women allocated to intermittent auscultation. There were no differences between groups in other secondary outcome measures.
Authors' conclusions
Contrary to continued use in some clinical areas, we found no evidence of benefit for the use of the admission cardiotocograph (CTG) for low-risk women on admission in labour.
We found no evidence of benefit for the use of the admission CTG for low-risk women on admission in labour. Furthermore, the probability is that admission CTG increases the caesarean section rate by approximately 20%. The data lacked power to detect possible important differences in perinatal mortality. However, it is unlikely that any trial, or meta-analysis, will be adequately powered to detect such differences. The findings of this review support recommendations that the admission CTG not be used for women who are low risk on admission in labour. Women should be informed that admission CTG is likely associated with an increase in the incidence of caesarean section without evidence of benefit.
P L A I N L A N G U A G E S U M M A R Y

Comparing electronic monitoring of the baby's heartbeat on a woman's admission in labour using cardiotocography (CTG) with intermittent monitoring
Monitoring of the fetal heart rate (FHR) is one of the most common methods for checking a baby's wellbeing. The two most common ways of monitoring the FHR are by listening to the heart beat using a fetal stethoscope, Pinard (special trumpet shaped device), handheld Doppler ultrasound device (this is known as intermittent auscultation) or by an electronic fetal monitoring (EFM) machine that produces a paper printout of the baby's heart rate and the mother's contractions, called a cardiotocograph (CTG) . The admission CTG is a commonly used test consisting of a short, usually 20 minute, recording of the FHR and uterine activity that is performed when the mother is admitted to the labour ward with signs of labour. The admission CTG was introduced to try and identify those babies who were at greatest risk of becoming compromised with a lack of oxygen during labour. These babies could be monitored more intensively by continuous electronic fetal monitoring, or they may benefit from an immediate intervention such as being delivered by caesarean section.
This review compared the admission CTG with intermittent auscultation of the FHR performed on the mother's admission to the labour ward. We included four randomised controlled trials involving more than 13,000 women with low-risk pregnancies in the review. Women allocated to admission CTG were more likely to have a caesarean section than women allocated to intermittent auscultation. There was no difference in the number of instrumental vaginal births or in the number of babies who died during or shortly after labour between women allocated to admission CTG and women allocated to intermittent auscultation. Admission CTG was associated with a significant increase in the use of continuous electronic fetal monitoring (with an electrode placed on the baby's scalp) and fetal blood sampling (a small blood sample taken from a baby's scalp) during labour. There were no differences in other outcomes measured such as artificial rupture of the membranes, augmentation of labour or use of an epidural.
B A C K G R O U N D
Assessment of fetal wellbeing throughout pregnancy, labour and birth is widely regarded as a fundamental component of maternity care and essential for optimising fetal outcomes. Although a variety of methods are used to assess fetal well-being, including fetal movement counting and biophysical tests such as Doppler ultrasound, monitoring of the fetal heart rate (FHR) remains the most common method for the assessment of fetal wellbeing.
The FHR undergoes constant changes in response to changes in the intrauterine environment and to other stimuli such as uterine contractions. These changes in the FHR can be monitored to assess the wellbeing of the fetus during pregnancy and labour.
Description of the condition
The two most common methods of monitoring the FHR are by intermittent auscultation and by an electronic fetal monitoring (EFM) machine that produces a paper printout called a cardiotocograph (CTG). Intermittent auscultation involves listening to the fetal heart at predetermined intervals using either a Pinard stethoscope or a hand-held Doppler ultrasound device. The CTG is a graphical printout of the FHR and uterine contractions. The FHR recorded on a CTG may be recorded externally via an ultrasound transducer attached to the mother's abdomen, or internally via a fetal scalp electrode placed directly on the baby's head. Uterine contractions are recorded via a pressure transducer attached to the mother's abdomen or, less commonly, by an intrauterine pressure device placed in the uterine cavity.
Description of the intervention
The admission CTG is a commonly used screening test consisting of a short, usually 20 minute, recording of the FHR and uterine activity performed on the mother's admission to the labour ward with signs of labour. Currently, some women will have an admission CTG performed prior to assessments aimed at diagnosing the onset of labour, while others will not have the admission CTG until a diagnosis of labour has been established. The implications of this are that some women will have an admission CTG performed on admission to the labour ward or labour assessment room where, on subsequent assessment, a diagnosis of not being in labour is made. Differences in timing of the admission CTG with respect to the onset of labour may result in differences in outcomes assessed. We planned to explore this through subgroup analysis (see 'Subgroup analysis and investigation of heterogeneity').
How the intervention might work
Pioneered in the 1950s and 1960s as an alternative to intermittent auscultation of the FHR by stethoscope or Pinard (Caldeyro-Barcia 1966; Hammacher 1968; Hon 1958) , EFM was introduced into widespread clinical practice in the 1970s to 1980s on the premise that it would facilitate early detection of abnormal FHR patterns thought to be associated with hypoxia (lack of oxygen), thus allowing earlier intervention to prevent fetal neurological damage and/or death (Nelson 1996) . However, because antenatal risk factors do not identify all fetuses who will subsequently experience morbidity and/or mortality, the admission CTG was introduced as a means of attempting to identify those fetuses of low-risk mothers at greatest risk of intrapartum hypoxia (Arulkumaran 2000; RCOG 2001 ) who might benefit from more intensive monitoring by continuous EFM and/or fetal scalp blood gas analysis or from immediate intervention (e.g. expedited birth). Current prevalence rates of perinatal mortality, neonatal encephalopathy and cerebral palsy are relatively low and, of those, only a small proportion are thought to be attributable directly to intrapartum causes (RCOG 2001) . Changes in FHR patterns are neither sensitive (the ability of a test to identify those who have the disease/condition) nor specific (the ability of the test to correctly identify those without the disease/condition) to any particular cause (MacLennan 1999) . Multiple late decelerations and decreased FHR variability have been shown to be associated with an increased risk of cerebral palsy (Nelson 1996) . However, the associated false positive rate is reported as high as 99.8% in the presence of tracings displaying these abnormalities in the FHR pattern (Nelson 1996) . This poor positive predictive value implies that to identify the fetus who may be compromised, EFM identifies abnormal FHR patterns in many healthy fetuses who are not truly compromised.
Why it is important to do this review
There is a lack of evidence of benefit supporting the use of the admission CTG in low-risk pregnancy. Despite recommendations that it should not be recommended for this group of women (Liston 2007; NCCWCH 2007; RCOG 2001) , the admission CTG was used by approximately 79% of maternity units in the UK in 2000 (CESDI 2001) , by 96% of units in Ireland in 2004 (Devane 2007 and by approximately 76% of Canadian hospitals (Kaczorowski 1998). More recently, the admission CTG was used in all (100%, n = 42) labour units in Sweden in 2008 (Holzmann 2010 . Although the admission CTG remains in widespread use, several issues remain controversial. These include whether the admission CTG (a) should be offered routinely to all women without risk factors for intrapartum hypoxia; (b) whether the admission CTG is effective at predicting those fetuses who will subsequently develop intrapartum hypoxia; and (c) the effect of the admission CTG on neonatal mortality and on maternal and neonatal morbidity. It is important to undertake this systematic review to explore these issues and to evaluate the efficacy of admission CTG compared to intermittent auscultation as a method of assessing fetal wellbeing in women on admission to the labour ward, or labour assessment room, with signs of possible labour. This review compliments other Cochrane systematic reviews evaluating the effectiveness of other interventions for the assessment of fetal wellbeing including the following.
• Antenatal cardiotocography for fetal assessment (Grivell 2010)
• Regimens of fetal surveillance for impaired fetal growth • Amniotic fluid index versus single deepest vertical pocket as a screening test for predicting adverse pregnancy outcomes (Nabhan 2008)
• Biophysical profile for fetal assessment in high-risk pregnancies (Lalor 2008) 
O B J E C T I V E S
To compare the effects of admission cardiotocograph with intermittent auscultation of the FHR on maternal and infant outcomes for pregnant women without risk factors for intrapartum hypoxia on their admission to the labour ward.
M E T H O D S
Criteria for considering studies for this review
Types of studies
All randomised and quasi randomised trials comparing admission cardiotocograph (CTG) with intermittent auscultation of the FHR.
Types of participants
Pregnant women between 37 and 42 completed weeks of pregnancy and considered to be at low risk of intrapartum fetal hypoxia and of developing complications during labour. It is recognised that there is much debate surrounding the definition of what constitutes 'normality' and concerns have been expressed at what some regard as the disempowering concept of risk classification (Gail-Thomas 2003) . In addition, the predictive value of risk scoring during pregnancy is poor (WHO 1999) . However, given the consensus of opinion that continuous electronic fetal monitoring should be reserved for women whose fetuses are at high or increased risk of cerebral palsy, neonatal encephalopathy or perinatal death (Liston 2007; NCCWCH 2007; RANZCOG 2002; RCOG 2001 ), we will, where sufficient detail is provided by trial authors, determine eligibility of participants based on absence of risk factors identified in international guidelines for electronic fetal monitoring (see Characteristics of included studies).
Types of interventions
Admission CTG compared with intermittent auscultation of the FHR on admission to the labour ward. For the purpose of this review we have used the following operational definitions.
• Admission CTG is defined as a commonly used screening test consisting of a short, usually 20 minute, recording of the FHR and uterine activity performed on the mother's admission to the labour ward.
• Intermittent auscultation is defined as intermittent surveillance of the FHR at predetermined intervals, using either a Pinard stethoscope or a hand-held Doppler, performed on the mother's admission to the labour ward. 5. weekly current awareness alerts for a further 44 journals plus monthly BioMed Central email alerts. Details of the search strategies for CENTRAL, MEDLINE and EMBASE, the list of handsearched journals and conference proceedings, and the list of journals reviewed via the current awareness service can be found in the 'Specialized Register' section within the editorial information about the Cochrane Pregnancy and Childbirth Group. Trials identified through the searching activities described above are each assigned to a review topic (or topics). The Trials Search Co-ordinator searches the register for each review using the topic list rather than keywords. In addition, we searched CENTRAL (The Cochrane Library 2011, Issue 2 of 4), MEDLINE (1966 to 17 May 2011 ), CINAHL (1982 to 17 May 2011 ) and Dissertation Abstracts (1980 to 17 May 2011 using the search strategies detailed in Appendix 1.
Types of outcome measures
Searching other resources
We searched the reference list of papers identified through the above search strategy and assessed their suitability for inclusion in the review. We did not apply any language restrictions.
Data collection and analysis
The methodology for data collection and analysis is based on the Cochrane Handbook of Systematic Reviews of Interventions (Higgins 2011).
Selection of studies
Two review authors (Declan Devane (DD) and Joan G Lalor (JGL)) assessed independently for inclusion all the potential studies identified as a result of the search strategy. We did not encounter any disagreement and therefore did not need to consult a third review author (Sean Daly (SD), William McGuire (WM) or Valerie Smith (VS)).
Data extraction and management
We designed a form to extract data. For eligible studies, two review authors (DD and JGL) extracted data using the data extraction form. We resolved any discrepancies through discussion and did not need to consult a third review author. Two review authors (DD and JGL) entered all data into the Review Manager (RevMan) software (RevMan 2011) and checked for accuracy. When information regarding any of the above was unclear, we attempted to contact authors of the original reports to provide further details.
Assessment of risk of bias in included studies
Two review authors (DD and VS) assessed the risk of bias for each study independently using The Cochrane Collaboration's tool for assessing risk of bias as outlined in the Cochrane Handbook for Systematic Reviews of Interventions (Higgins 2011) and contained in RevMan (RevMan 2011).
(1) Sequence generation (checking for possible selection bias)
We described for each included study the method used to generate the allocation sequence in sufficient detail to allow an assessment of whether it should produce comparable groups. We assessed the risk of bias for sequence generation:
• low risk (any truly random process, e.g. random number table; computer random number generator);
• high risk (any non-random process, e.g. odd or even date of birth; hospital or clinic record number); or
• unclear risk.
(2) Allocation concealment (checking for possible selection bias)
We described for each included study the method used to conceal the allocation sequence and determined whether intervention allocation could have been foreseen in advance of, or during recruitment, or changed after assignment. We assessed the risk of bias for allocation concealment
• low risk (e.g. telephone or central randomisation; consecutively numbered sealed opaque envelopes);
• high risk (open random allocation; unsealed or non-opaque envelopes, alternation; date of birth);
• unclear risk. It is likely not possible to blind participants or personnel in these trials. Given the differences in equipment required, it is usually apparent to both women and clinicians to which group a woman has been randomised (i.e. admission cardiotocograph or intermittent auscultation with Pinard or hand-held Doppler device). However, it would be possible to blind outcome assessors. Therefore, we assessed the risk of bias for blinding for outcome assessors as:
• high risk;
• low risk;
• unclear risk. For each included study, and for each outcome or class of outcomes, we describe completeness of data including attrition and exclusions from the analysis. We noted whether attrition and exclusions were reported, the numbers included in the analysis at each stage (compared with the total randomised participants), reasons for attrition or exclusion where reported, and whether missing data were balanced across groups or were related to outcomes. Where sufficient information was reported, or was supplied by the trial authors, we re-included missing data in the analyses we undertook. We assessed the risk of bias for completeness of data as:
• low risk (20% or less missing data);
• high risk (more than 20% missing data);
(5) Selective reporting bias
We investigated the possibility of selective outcome reporting bias by identifying all outcomes reported in the methods section of the results publication and cross-checking to see if these were reported in the results section of the trial publication(s). We assessed the risk of bias for selective reporting as:
• high risk (where not all the study's pre-specified outcomes have been reported; one or more reported primary outcomes were not pre-specified; outcomes of interest are reported incompletely and so cannot be used; study failed to include results of a key outcome that would have been expected to have been reported);
• low risk (where it was clear that all of the study's prespecified outcomes and all expected outcomes of interest to the review have been reported);
(6) Other sources of bias
We described for each included study any important concerns we had about other possible sources of bias. We assessed whether each study was free of other problems that could put it at risk of bias. We judged the risk of bias as:
(7) Overall risk of bias
We made explicit judgements about whether studies were at high risk of bias, according to the criteria given in the Handbook ( Higgins 2011). With reference to (1) to (6) above, we assessed the likely magnitude and direction of the bias and whether we considered it as likely to have impacted on the findings. We assessed the overall risk of bias for each included study as:
Measures of treatment effect Dichotomous data
For dichotomous data, we present results as summary risk ratios with 95% confidence intervals.
Continuous data
For continuous data, we used the mean difference where outcomes were measured in the same way between trials.
Unit of analysis issues Cluster-randomised trials
We did not find any cluster-randomised trials from our search. In future updates, if we identify cluster-randomised trials we will include them in the analyses along with individually randomised trials. We will adjust their sample sizes using the methods described in the Handbook using an estimate of the intracluster correlation coefficient (ICC) derived from the trial (if possible), from a similar trial or from a study of a similar population. If we use ICCs from other sources, we will report this and conduct sensitivity analyses to investigate the effect of variation in the ICC. If we identify both cluster-randomised trials and individually-randomised trials, we plan to synthesise the relevant information. We will consider it reasonable to combine the results from both if there is little heterogeneity between the study designs and the interaction between the effect of intervention and the choice of randomisation unit is considered to be unlikely. We will also acknowledge heterogeneity in the randomisation unit and perform a sensitivity analysis to investigate the effects of the randomisation unit.
Dealing with missing data
For included studies, we noted levels of attrition. We explored the impact of including studies with high levels of missing data in the overall assessment of treatment effect by using Sensitivity analysis. For all outcomes, we carried out analyses, as far as possible, on an intention-to-treat basis, i.e. we attempted to include all participants randomised to each group in the analyses, and analysed all participants in the group to which they were allocated, regardless of whether or not they received the allocated intervention. The denominator for each outcome in each trial was the number of women randomised minus any participants whose outcomes are known to be missing.
Assessment of heterogeneity
We assessed statistical heterogeneity in each meta-analysis using the T², I² and Chi² statistics. We regarded heterogeneity as substantial where T² was greater than zero and either I² was greater than 30% or there was a low P value (less than 0.10) in the Chi² test for heterogeneity.
Assessment of reporting biases
In future updates, if there are 10 or more studies in the meta-analysis we will investigate reporting biases (such as publication bias) using funnel plots. We will assess funnel plot asymmetry visually, and use formal tests for funnel plot asymmetry. For continuous outcomes we will use the test proposed by Egger 1997, and for dichotomous outcomes we will use the test proposed by Harbord 2006. If we detect asymmetry in any of these tests or by a visual assessment, we will perform exploratory analyses to investigate it.
Data synthesis
We carried out statistical analyses using the Review Manager software (RevMan 2011). The largest of the four included trials (Impey 2003) included women in whom the liquor was known to be clear (i.e. only women who had either a spontaneous rupture of the membranes or an amniotomy were included in the study). This knowledge of the presence of clear liquor would have given clinicians an additional clinical feature used in the assessment of fetal well being that would not have been available for all women included in the other three trials (Cheyne 2003; Mires 2001; Mitchell 2008) where membrane rupture and clear liquor were not inclusion criteria. Because of this, we believed that there was clinical heterogeneity sufficient to expect that the underlying treatment effects would differ between the included trials (and in particular between the Impey 2003 trial and the other three trials (Cheyne 2003; Mires 2001; Mitchell 2008) ). We therefore used random-effects meta-analysis to produce an overall summary of the average treatment effect across the four included trials. We have treated this random-effects summary as the average range of possible treatment effects. For each outcome reported, we present the results of the random-effects analyses as the average treatment effect with its 95% confidence interval, and the estimates of T² and I².
Subgroup analysis and investigation of heterogeneity
We planned to carry out the following subgroup analysis using a priori outcomes.
1. Women in-labour versus women not in-labour on clinical assessment post admission cardiotocograph. However, all four studies included only women in labour (at point of intervention) and therefore this subgroup analysis was not possible. We will perform this subgroup analysis in future updates if data are available. For fixed-effect inverse variance meta-analyses we will assess differences between subgroups by interaction tests. For random-effects and fixed-effect meta-analyses using methods other than inverse variance, we will assess differences between subgroups by inspection of the subgroups' confidence intervals; nonoverlapping confidence intervals indicate a statistically significant difference in treatment effect between the subgroups.
Sensitivity analysis
We had planned to perform a sensitivity analysis based on trial quality, separating high-quality trials from trials of lower quality. 'High quality' was, for the purposes of this sensitivity analysis, defined as a trial having 'low risk of bias' for allocation concealment and a reasonable loss to follow-up (less than 20% of outcome data). However, we assessed all four included studies as having low risk of bias in random sequence generation and allocation concealment and none had more than 20% outcome data missing for outcomes included in this review. Therefore, the planned sensitivity analysis was not required but may be carried out in future updates if data permit. We investigated substantial statistical heterogeneity (see Assessment of heterogeneity) using sensitivity analyses.
R E S U L T S Description of studies
See: Characteristics of included studies; Characteristics of ongoing studies.
Results of the search
The search of the Cochrane Pregnancy and Childbirth Group's Trials Register found seven reports and our search of the other databases did not identify any additional reports. These seven reports related to four completed (Cheyne 2003; Impey 2003; Mires 2001; Mitchell 2008) and one ongoing study (Devane 2008) .
Included studies
We included four studies with 13,296 women ( 
Excluded studies
We did not exclude any studies.
Risk of bias in included studies
We assessed the risk of bias in included studies within the domains of (i) random sequence generation (selection bias) (ii) allocation concealment (selection bias) (iii) blinding of outcome assessment (detection bias) (iv) incomplete outcome data (attrition bias) (v) selective reporting (reporting bias) (vi) other bias and (vi) overall risk of bias (see Assessment of risk of bias in included studies above). Overall, the studies were at low risk of bias across most domains with some exceptions, which are detailed below.
Allocation
We assessed all four included studies as having low risk of bias in random sequence generation and in allocation concealment.
Blinding
We felt it unreasonable to expect blinding of participants and professionals providing care (see Assessment of risk of bias in included studies). Risk of bias for blinding for outcome assessors was assessed as low for two studies (Impey 2003; Mires 2001) , unclear for one (Mitchell 2008) and high risk in one where outcome assessment was not blinded (Cheyne 2003) .
Incomplete outcome data
Overall, loss to follow-up was low across all outcomes for all four studies with the exception of umbilical cord blood gas analyses (arterial pH, venous pH and base deficit/base excess (BD/BE)). Two studies included this outcome (Impey 2003; Mires 2001) but the range of values used for this outcome in both these studies differed from that prespecified in this review and therefore we have not used these data. For information, Impey 2003 reports missing data for the outcome 'pH less than seven or BD/E greater than 12 mmol/L' of 7.5% and 7.8% for ACTG and IA respectively. Mires 2001 reports missing data for their primary outcome of metabolic acidosis defined as 'pH less than 7.20 or BD greater than 8 mmol/ L' of 26% and 27% for ACTG and IA respectively. One study reported a loss to follow-up of 7% (n = 22) of women (Cheyne 2003) . However, data were identified and extracted subsequently for 21 of these 22 women by the trial author and kindly provided to the review team.
Selective reporting
All four studies reported all outcomes mentioned in the methods section in the results section of the trial publication(s) and were therefore assessed as being at low risk of selective reporting.
Other potential sources of bias
We identified no other sources of potential bias in three of the four studies (Cheyne 2003; Impey 2003; Mitchell 2008) . One study (Mires 2001) recruited women (n = 3752) to the study and randomised them to admission CTG or intermittent auscultation during the third trimester. However, some women developed an obstetric complication between randomisation and admission in labour that warranted continuous FHR monitoring in labour, such that only 2367 women were judged to be low risk when in labour (1186 admission CTG, 1181 intermittent auscultation). Of the 1885 women randomised to intermittent auscultation in the third trimester, 704 (37%) developed complications during pregnancy and required admission CTG on admission. This is addressed further under Sensitivity analysis. 
Effects of interventions
Primary outcomes
The difference in the average treatment effect across included trials between women allocated to admission CTG and women allocated to intermittent auscultation in caesarean section has a risk ratio (RR) of 1.20 and a 95% confidence interval (CI) of 1.00 to 1.44, four trials, 11,338 women, Analysis 1.1). Given that (i) the 95% CI just reaches 1.00 and (ii) the absence of measurable heterogeneity in this outcome analysis (T² = 0.00, I² = 0%), the probability is that admission CTG increases the caesarean section rate by approximately 20%. There was no significant difference in the average treatment effect across included trials between women allocated to admission CTG and women allocated to intermittent auscultation in instrumental vaginal birth (RR 1.10, 95% CI 0.95 to 1.27, four trials, 11,338 women, T² = 0.01, I² = 38%, Analysis 1.2) and fetal and neonatal deaths (RR 1.01, 95% CI 0.30 to 3.47, four trials, 11339 infants, T² = 0.00, I² = 0%, Analysis 1.8). None of the included studies reported data for the outcome 'Severe neurodevelopmental disability assessed at greater than, or equal to, 12 months of age'.
Secondary outcomes
Women allocated to admission CTG had, on average, significantly higher rates of continuous electronic fetal monitoring during labour (RR 1.30, 95% CI 1.14 to 1.48, three trials, 10753 women, T² = 0.01, I² = 79%, Analysis 1.3) and fetal blood sampling (RR 1.28, 95% CI 1.13 to 1.45, three trials, 10757 women, T² = 0.00, I² = 0%, Analysis 1.7) than women allocated to intermittent auscultation. There was no significant difference in the average treatment effect across included trials between women allocated to admission CTG and women allocated to intermittent auscultation in amniotomy (RR 1.04, 95% CI 0.97 to 1.12, two trials, 2694 women, T² = 0.00, I² = 0%, Analysis 1.4), oxytocin for augmentation of labour (RR 1.05, 95% CI 0.95 to 1.17, four trials, 11,324 women, T² = 0.00, I² = 34%, Analysis 1.5), epidural (RR 1.11, 95% CI 0.87 to 1.41, three trials, 10,757 women, T² = 0.03, I² = 86%, Analysis 1.6), Apgar score less than seven at or after five minutes (RR 1.00, 95% CI 0.54 to 1.85, four trials, 11,324 infants, T² = 0.10, I² = 25%, Analysis 1.11), hypoxic ischaemic encephalopathy (RR 1.19, 95% CI 0.37 to 3.90, one trial, 2367 infants, heterogeneity not applicable, Analysis 1.12), admission to neonatal intensive care units (RR 1.03, 95% CI 0.86 to 1.24, four trials, 11,331 infants, T² = 0.00, I² = 0%, Analysis 1.10), neonatal seizures (RR 0.72, 95% CI 0.32 to 1.61, one trial, 8056 infants, heterogeneity not applicable, Analysis 1.13), evidence of fetal multi-organ compromise within the first 24 hours after birth (RR 0.56, 95% CI 0.19 to 1.67, one trial, 8056 infants, heterogeneity not applicable, Analysis 1.9), length of stay in neonatal intensive care (hours) (mean difference (MD) 6.20 hours, 95% CI -8.70 to 21.10, one trial, 318 infants, heterogeneity not applicable, Analysis 1.15) and length of stay in neonatal intensive care (days) (MD 1.80, 95% CI -0.59 to 4.19, one trial, 91 infants, heterogeneity not applicable, Analysis 1.14). Data were not reported, were unavailable or were unavailable in a format that could be used in this review for the following secondary outcomes.
Maternal
1. Incidence of serious maternal complications (e.g. admission to intensive care unit, septicaemia (a form of blood infection), organ failure).
2. Mobility during labour. 3. Perceived control and/or self-confidence during labour. 4. Incidence of use of non pharmacological methods of coping with labour, e.g. transcutaneous electrical nerve stimulation, hydrotherapy.
5. Satisfaction with labour experience. 6. Length of hospital stay.
Sensitivity analyses
One study (Mires 2001) recruited women (n = 3752) to the study and randomised them to admission CTG or intermittent auscultation during the third trimester. However, some women developed an obstetric complication between randomisation and admission in labour that warranted continuous FHR monitoring in labour, such that only 2367 women were judged to be at low risk when in labour (1186 admission CTG, 1181 intermittent auscultation). Of the 1885 women randomised to intermittent auscultation in the third trimester, 704 (37%) developed complications during pregnancy and required an admission CTG on admission to the labour ward. However, the proportion of women who developed complications were similar in each group, suggesting an absence of differential treatment of women post-randomisation. The trial author kindly provided data separately for the outcomes in this subgroup of women, and we have included these data in the main analyses in this review (see Characteristics of included studies). A second study (Impey 2003) randomised women at the point of labour. However, this study included a relatively small number (less than 5%) of women who had a previous lower segment caesarean section and who went into labour prior to 37 completed weeks' gestation. The trial author kindly provided data separately for the outcomes for women (i) between 37 and 42 completed weeks with (ii) no previous caesarean section and we have included these data in the main analyses in this review. We explored the dependency of the findings of this review on the decision to use data from the low-risk subgroups of women in both the Impey 2003 and Mires 2001 studies through a post-hoc sensitivity analysis in which the primary analysis was repeated with data from the whole groups as randomised in both studies. Results for this were consistent with primary comparison effects for the low-risk subgroup of women with the exception of two outcomes. Caesarean section became statistically significant, with significantly more women allocated to admission CTG having, on average, a caesarean section compared with women allocated to intermittent auscultation (RR 1.17, 95% CI 1.02 to 1.34, four trials, 13247 women, T² = 0.00, I² = 0%, Analysis 2.1). Epidural also became significant, with significantly more women allocated to intermittent auscultation having, on average, an epidural compared with women allocated to admission CTG (RR 1.11, 95% CI 1.01 to 1.22, two trials, 4085 women, T² = 0.00, I² = 0%, Analysis 2.6).
In the primary comparison, three outcomes (instrumental vaginal birth, continuous electronic fetal monitoring during labour and epidurals) had significant statistical heterogeneity where T² was greater than zero and either I² was greater than 30% or there was a low P value (less than 0.10) in the Chi² test for heterogeneity. On investigating this heterogeneity, we found that the Mires 2001 study appeared to drive the heterogeneity for instrumental vaginal birth and continuous electronic fetal monitoring during labour. When Mires 2001 was removed from each of these two outcomes, the heterogeneity was no longer substantial. Removal of Mires 2001 for each of these two outcomes did not alter the direction or significance of the effect. Heterogentity for the third outcome, epidural, seemed to be driven by Impey 2003, which in contrast to the direction of effect of the other two studies included in this outcome, found a non-significant reduction in epidurals in women allocated to admission CTG. The admission cardiotocograph (CTG) was introduced as a means of attempting to identify those fetuses at greatest risk of intrapartum hypoxia (Arulkumaran 2000; RCOG 2001) who might benefit from more intensive monitoring by continuous electronic fetal monitoring and/or fetal scalp blood gas analysis or from immediate intervention (e.g. expedited birth). Although there was no significant difference, using a strict P = 0.05 criterion, in caesarean sections, on average, between women allocated to admission CTG and women allocated to intermittent auscultation, the probability is that admission CTG increases the caesarean section rate by approximately 20%. This is reinforced by the 95% CI just reach-ing 1.00 and by the absence of measurable heterogeneity in this outcome analysis. Further, all four included studies found fewer caesarean sections associated with intermittent auscultation, although no individual study showed a statistically significant difference. Although numbers needed to treat/harm (NNT/H) analyses remain controversial in the context of meta-analysis and should be interpreted with caution, we estimate that, overall, one additional caesarean section was performed for every 136 women monitored continuously (95% CI 69 to 5641, risk difference (controlstreated) = -0.0074 (-0.015 to -0.0002)).
D I S C U S S I O N
Women allocated to admission CTG had a significantly higher rate, on average, of continuous electronic fetal monitoring during labour and fetal blood sampling than women allocated to intermittent auscultation.
All four included studies provide relevant evidence on the effects of the admission CTG compared with intermittent auscultation on maternal and infant outcomes for pregnant women without risk factors on their admission to the labour ward. There are three important points in discussing how the results of the review fit into the context of current practice. Firstly, the largest study in this review (Impey 2003) included women in which the colour of the liquor was known to be clear. As such, clinicians caring for these women had an additional, and important, feature used in the overall assessment of fetal wellbeing. Secondly, all four studies included women in either spontaneous or induced labour. In some practice contexts, the admission CTG is performed in the absence of a diagnosis of labour, i.e. an admission CTG is done before an assessment to diagnose labour is made. Thirdly, in the Mitchell 2008, women allocated to admission CTG received a routine 15-minute CTG. This is less than the 20 minutes recommended for visual assessment of FHR reactivity by some guidelines (RCOG 2001) . These points should be considered in determining the applicability of the evidence presented here to different practice contexts.
It is reasonable to assume that outcomes related to perinatal death are perhaps those of most importance to women and maternity care professionals. In this review, there was no significant difference in perinatal mortality between admission CTG and intermittent auscultation. However, to identify correctly a 20% reduction in proportion of perinatal deaths (assuming a developed world rate of seven per 1000) between admission CTG and intermittent auscultation, a sample size of more than 100,000 is required (with α = 0.05, β-1 = 20%) and even then a 20% reduction might be regarded as optimistic, with lower effect sizes requiring higher sample sizes. Such sample sizes are unlikely, except perhaps in the largest of mega-trials and, therefore, typical randomised trials and systematic reviews of these trials, including this review, have insufficient power to evaluate the effects of different fetal monitoring modalities on fetal and neonatal mortality measures. Therefore, while this review found no evidence of an effect for admission CTG on perinatal mortality, this should not be confused with evidence of no effect.
There are important outcomes, though secondary, which are not reported, are unavailable or are not in a suitable format to be included in the analysis; these include perceived control and satisfaction with labour. This reflects a widespread tendency among the clinical and research community to frame outcomes in a non-salutogenic or pathological manner (e.g. operative birth) rather than in a salutogenic, wellbeing orientated manner (e.g. normal birth). It may also reflect the relative difficulty of quantifying outcomes that are subjective and difficult, although important, to 'measure'. Overall, risk of bias of the four included studies was assessed as low across all domains assessed with the exception of blinded outcome assessment, which was unclear in one study (Mitchell 2008) and not carried out in another (Cheyne 2003) . Of the 3752 women randomised during the third trimester in the study by Mires 2001, 37% developed an obstetric complication between randomisation and admission in labour that warranted continuous FHR monitoring in labour. Specific complications are given and these are in line with clinical norms reported in the literature. The study by Impey 2003 also included a small proportion of women with risk factors. Both Impey 2003 and Mires 2001 provided data for the sub-group of low-risk women, and these data are used in the main analyses in this review. Sensitivity analyses were done in which the outcomes for all randomised women were used. Results were consistent with the primary comparison effects, with the exception of two outcomes. Caesarean section became statistically significant, with significantly more women allocated to admission CTG having, on average, a caesarean section compared with women allocated to intermittent auscultation. Epidural also became significant, with significantly more women allocated to intermittent auscultation having, on average, an epidural compared with women allocated to admission CTG. However, these findings should be interpreted with caution. For the outcome caesarean section in whole-group comparison, Mires 2001 contributes most weight to the meta-analysis. However, in this study and as mentioned earlier, 37% (n = 704) of women randomised to intermittent auscultation developed complications during pregnancy and required admission CTG on admission.
A U T H O R S ' C O N C L U S I O N S Implications for practice
Contrary to continued use in some clinical areas, we found no evidence of benefit for the use of the admission cardiotocograph (CTG) for low-risk women on admission in labour. Furthermore, the probability is that admission CTG increases the caesarean section rate by approximately 20%. The data lacked power to detect possible important differences in perinatal mortality. However, it is unlikely that any trial, or meta-analysis, will be adequately powered to detect such differences. The findings of this review supports recommendations that the admission CTG not be used for women who are low risk on admission in labour (Liston 2007; NCCWCH 2007; RCOG 2001) . Women should be informed that admission CTG is likely associated with an increase in the incidence of caesarean section without evidence of benefit.
It is important to note that all four trials included in this review were conducted in developed Western European countries. The usefulness of the findings of this review for developing countries will depend on FHR monitoring practices. However, an absence of benefit and likely harm associated with admission CTG will have relevance for countries where questions are being asked about the role of the admission CTG.
Implications for research
All four included studies used the admission CTG on women in spontaneous or induced labour. Future studies evaluating the effects of the admission CTG should consider including women admitted with signs of labour and prior to a formal diagnosis of labour. This would include a cohort of women currently having admission CTGs and not included in current trials. The largest study in this review includes women where the colour of the liquor was known to be clear. Additional studies that evaluate the effects of the admission CTG on women where the colour of the amniotic fluid is not known are needed. Our thanks also to Prof Mike Clarke for helpful discussions around group comparisons that informed this review methodology.
A C K N O W L E D G E M E N T S
As part of the pre-publication editorial process, this review has been commented on by three peers (an editor and two referees who are external to the editorial team), a member of the Pregnancy and Childbirth Group's international panel of consumers and the Group's Statistical Adviser. 
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C H A R A C T E R I S T I C S O F S T U D I E S
Characteristics of included studies [ordered by study ID]
Cheyne 2003
Methods
Study design: RCT. Duration of study: 1999.
Participants Setting: Glasgow Royal Maternity Hospital, Scotland. Inclusion criteria: healthy women who had experienced a normal pregnancy, presented at term in spontaneous labour and were eligible for admission to the Midwives Birth Unit. Exclusion criteria: women with risk factors. Participants randomised: 334 women (157 admission CTG (referred to as 'control group' in paper), 177 intermittent auscultation (referred to as 'study group' in paper)) Randomisation on admission in labour.
Interventions Admission CTG: a routine 20-minute period of EFM at the time of admission. Intermittent auscultation: the fetal heart was auscultated during and immediately following a contraction for a minimum of 60 seconds Outcomes Outcomes considered in the review and reported in or extracted from the study: caesarean section; instrumental vaginal birth; continuous EFM during labour; amniotomy; oxytocin for augmentation of labour; epidural; fetal blood sampling; fetal and neonatal deaths; Apgar score < 7 at or after 5 minutes; admission to neonatal intensive care.
Notes
Unpublished data to permit re-inclusion of women to groups as randomised kindly provided by author
Risk of bias
Bias
Authors' judgement Support for judgement
Random sequence generation (selection bias)
Low risk '...computer-generated in order to allocate participants equally between the two groups...'
Allocation concealment (selection bias) Low risk '...sequentially numbered, sealed opaque envelopes, which contained allocation to the appropriate group.'
Blinding of outcome assessment (detection bias) All outcomes
High risk Not blinded.
Incomplete outcome data (attrition bias) All outcomes
Low risk Loss to follow-up: in the trial report 22 women (7%) are excluded from the analysis (21 women entered into the study and found not to be in labour and 1 randomisation card missing). However, data for these 21 of 22 women was identified and extracted subsequently by the trial author and kindly provided to the review team Selective reporting (reporting bias) Low risk All outcomes stated in the methods section were reported adequately in results
Other bias Low risk None identified.
Overall risk of bias Low risk
Impey 2003
Methods Study design: RCT. Duration of study: 1997-2001.
Participants
Setting: National Maternity Hospital in Dublin, Ireland. Inclusion criteria: women were eligible for inclusion if they were admitted in labour, a singleton pregnancy, fewer than 42 completed weeks of gestation, no suspicion or evidence of antenatal fetal compromise, no adverse obstetric history, clear amniotic fluid, and maternal temperature of 37.5°C or less at admission. Participants randomised: 8628 women (4320 admission CTG, 4308 intermittent auscultation) Randomisation on admission in labour. A relatively small number (< 5%) of women who had a previous caesarean section and who went into labour prior to 37 completed weeks' gestation were included in this study and were randomised. The trial author kindly provided data separately for the outcomes for women (i) between 37 and 42 completed weeks with (ii) an absence of previous caesarean section and these data are used in the main analyses in this review. Sensitivity analyses were done in which the outcomes for all randomised women were used Interventions Admission CTG: a 20-minute admission CTG immediately after early amniotomy done on diagnosis of labour in women presenting to the delivery ward Intermittent auscultation: intermittent auscultation was used for 1 minute after a contraction every 15 minutes in the first stage and every 5 minutes in the second stage of labour. This was done after early amniotomy on diagnosis of labour in women presenting to the delivery ward Incomplete outcome data (attrition bias) All outcomes
Low risk Loss to follow-up for the primary outcome of metabolic acidosis was high (admission CTG n = 310, 26% and intermittent auscultation n = 321, 27%). However, metabolic acidosis was defined as 'pH less than 7.20 or BD (Base Deficit) > than 8 mmol/L'. Data were unavailable for the outcome metabolic acidosis as defined in this review, i.e. 'pH less than 7 or BD/E (Base Deficit/Excess) > than 12 mmol/L', therefore this study does not provide data for this outcome in this review. All other outcomes had low rates of missing data, hence rating as 'low risk of bias'
Selective reporting (reporting bias) Low risk All outcomes stated in the methods section were reported adequately in results
Other bias Low risk 'Between randomisation during the third trimester of pregnancy and admission in labour, 1384 women (37%) developed an obstetric complication that warranted continuous fetal heart rate monitoring in labour' A total of 3752 women were recruited to the study and randomised during the third trimester. However, some women developed complications between randomisation and admission in labour, such that only 2367 women were judged to be low risk when in labour (1186 admission CTG, 1181 intermittent auscultation). There are similar levels of attrition in both groups due to development of complications suggesting that allocation concealment remained intact. The trial author kindly provided data separately for the outcomes in this lowrisk subgroup of women and these data are Review: Cardiotocography versus intermittent auscultation of fetal heart on admission to labour ward for assessment of fetal wellbeing Favours ACTG Favours IA
